Genetics finding its place in larger living schemes

Critical Public Health

Volumn 12, Issue 3, 2002, Pages 221-236

  Herbert, Martha R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CLINICAL GENETICS; DEVELOPMENTAL BIOLOGY; DISEASE ASSOCIATION; FINANCIAL MANAGEMENT; GENE TECHNOLOGY; GENETIC CODE; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MEDICAL RESEARCH; PATHOLOGY; PHYSIOLOGY; PREDICTION; PRODUCTIVITY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 0036751234     PISSN: 09581596     EISSN: None     Source Type: Journal    
DOI: 10.1080/09581590210153353     Document Type: Article

References (87)

1. Altieri, M. (2000) Agroecology in Action.http://www.cnr.berkeley.edu/~agroeco3/.
2. Ames, B.N. (2001) DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutation Research, 475, pp. 7-20.
3. Ames, B.N, Elson-Schwab, I. & Silver, E.A. (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. American Journal of Clinical Nutrition, 75, pp. 616-658.
4. Anonymous (2002) Editorial: Wag the dogma. Nature Genetics, 30, pp. 343-344.
5. Beck, U. (1999) World Risk Society (Cambridge, Polity Press).
6. Billings, P.R, Hubbard, R. & Newman, S.A. (1999) Human germline gene modification: a dissent. Lancet, 353, pp. 1873-1875.
7. Calver, M.C. (2000) Lessons from preventive medicine for the precautionary principle and ecosystem health. Ecosystem Health, 6, pp. 99-107.
8. Cavazzana-Calvo, M., Hacein-Bey, S., Yates, F., de Villartay, J.P., Le Deist, F. and Fischer, A. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, pp. 669-672.
9. Cohen, F.E. (2000) Prions, peptides and protein misfolding. Molecular Medicine Today, 6, pp. 292-293.
10. Collins, F.S, Weiss, L. & Hudson, K. (2001) Heredity and humanity: have no fear. genes aren't everything. New Republic http://www.thenewrepublic.com/062501/collinsO62501.html
11. Collins, T. (2001) Toward sustainable chemistry. Science, 291, pp. 48-49.
12. Commoner, B. (2002) Unraveling the DNA myth: the spurious foundation of genetic engineering. Harper's Magazine, 304, pp. 39-47.
13. Crick, F.H.C. (1958) On protein synthesis. Symposia for the Society of Experimental Biology, XII, pp. 139-163.
14. Davis, D.L., Axelrod, D., Bailey, L., Gaynor, M. & Sasco, A.J. (1998) Rethinking breast cancer risk and the environment: the case for the precautionary principle. Environmental Health Perspectives, 106, pp. 523-529.
15. De Jong, H.L. (2000) Genetic determinism-how not to interpret behavioral genetics. Theory & Psychology, 10, pp. 615-637.
16. Deeming, D.C. & Ferguson, M.W. (1988) Environmental regulation of sex determination in reptiles. Philosophical Transactions of the Royal Society of London B Biological Science, 322, pp. 19-39.
17. Dipple, K.M. & McCabe, E.R.B. (2000) Modifier genes convert 'simple mendelian disorders' to complex traits. Molecular Genetics and Metabolism, 71 pp. 43-50.
18. Elson-Schwab, I., Poedjosoedarmo, K. & Ames, B.N. (2002) KmMutants.org http://www.KmMutants.org.
19. Ewing, B. & Green, P. (2000) Analysis of expressed sequence tags indicates 35,000 human genes. Nature Genetics, 25, pp. 232-234.
20. Geiser, K. & Commoner, B. (2001) Materials Matter: Toward a Sustainable Materials Policy (Urban and Industrial Environments) (Cambridge, MA, MIT Press).
21. Gilbert, S.F. & Sarkar, S. (2000) Embracing complexity: organicism for the 21st century. Developmental Dynamics, 219, pp. 1-9.
22. Gillberg, C. & Coleman, M. (2000) The Biology of the Autistic Spectrums (Clinics in Developmental Medicine), 3rd end (Cambridge, UK, Cambridge University Press).
23. Grüneberg, H. (1963) The Pathology of Development: A Study of Inherited Skeletal Disorders in Animals (New York, Wiley).
24. Haag, D. & Kaupenjohann, M. (2001) Parameters, prediction, post-normal science and the precautionary principle-a roadmap for modelling for decision-making. Ecological Modelling, 144, pp. 45-60.
25. Haila, Y. & Taylor, P. (2001) The philosophical dullness of classical ecology, and a Levinsian alternative. Biology & Philosophy, 16, pp. 93-102.
26. Hersch, S., Jones, R, Koroshetz, W. & Quaid, K. (1994) The neurogenetics genie: testing for the Huntington's disease mutation. Neurology, 44 (8), pp. 1369-1373.
27. Holtzman, N.A. & Marteau, T.M. (2000) Will genetics revolutionize medicine? New England Journal of Medicine, 343 (2), pp. 141-144.
28. Howard, K. (2000) The bioinformatics gold rush. Scientific American, 283, pp. 58-63.
29. Huang, S. (2000) The practical problems of post-genomic biology. Nature Biotechnology, 18, pp. 471-472.
30. Hubbard, R. & Wald, E. (1999) Exploding the Gene Myth (Boston, Beacon Press).
31. Humpherys, D., Eggan, K., Akutsu, H., Hochedlinger, K., Rideout, W.M. III, Biniszkiewicz, D., Yanagimachi, R. & Jaenisch, R. (2001) Epigenetic instability in ES cells and cloned mice. Science, 293(5527), pp. 95-97.
32. Hyman, S.E. (2000) The genetics of mental illness: implications for practice. Bulletin of the World Health Organisation, 78, pp. 455-463.
33. Jenuwein, T. & Allis, C.D. (2001) Translating the Histone Code. Science, 293, p. 1074.
34. Kass, S.U. & Wolffe, A.P. (1998) DNA methylation, nucleosomes and the inheritance of chromatin structure and function. Novartis Foundation Symposia, 214, pp. 22-35.
35. Kay, L. (1993) The Molecular Vision of Life: Caltech, The Rockefeller Foundation, and the Rise of the New Biology (New York, Oxford University Press).
36. Kay, L. (2000) Who Wrote the Book of Life? (Stanford, CA, Stanford University Press).
37. Kaye, J.A. del Mar, Melero-Montes, M. & Jick, H. (2001) Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. British Medical Journal, 322, pp. 460-463.
38. Keller, E.F. (2000) The Century of the Gene (Cambridge, MA, Harvard University Press).
39. Kerr, A. & Cunningham-Burley, S. (2000) On ambivalence and risk: reflexive modernity and the new human genetics. Sociology, 34, pp. 283-304.
40. Kriebel, D., Tickner, J., Epstein, P., Lemons, J., Levins, R., Loechler, E.L., Quinn, M., Rudel, R., Schettler, T. & Stoto, M. (2001) The precautionary principle in environmental science. Environmental Health Perspectives, 109, pp. 871-876.
41. Lamb, J.A, Moore, J., Bailey, A. & Monaco, A.P. (2000) Autism: recent molecular genetic advances. Human Molecular Genetics, 9(6), pp. 861-868.
42. Le Fanu, J. (2000) The Rise and Fall of Modern Medicine (New York: Carroll & Graf).
43. Leboyer, M., Bellivier, F., Nosten-Bertrand, M., Jouvent, R., Pauls, D. & Mallet, J. (1998) Psychiatric genetics: search for phenotypes. Trends in Neuroscience, 21, pp. 102-105.
44. London, E.A. (2000) The environment as an etiologic factor in autism: a new direction for research. Environmental Health Perspectives, 108(Suppl. 3), 401-404.
45. Martin, G.R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Science of the USA, 78(12), pp. 7634-7638.
46. Martin, P. (1999) Genes as drugs: the social shaping of gene therapy and the reconstruction of genetic disease. In: Conrad, P. & Gabe, J. (eds) Sociological Perspectives on the New Genetics (Oxford, Blackwell), pp. 15-35.
47. McLaren, A, & Michie, D. (1958) An effect of the uterine environment upon skeletal morphology in the mouse. Nature, 181, pp. 1147-1148,
48. Monk, M. & Holding, C. (2001) Human embryonic genes re-expressed in cancer cells. Oncogene, 20 (56), pp. 8085-8091.
49. Montague, P. & Pellerano, M.B. (2001) Toxicology and environmental digital resources from and for citizen groups. Toxicology, 157, pp. 77-88.
50. More, M. (1999) The Extropian Principles, Version 3.0: A Transhumanist Declaration. http://www.extropy.com/extprn3.htm
51. Mozzarelli, A.H.J.E.W.A. (1987) Delay time of hemoglobin S polymerization revents most cells from sickling in vivo. Science, 237, pp. 500-506.
52. Nagel, R.L. (1999) Will the genetic individualization of disease force a new paradigm? Canadian Royal Academy of Science III, 322(1), pp. 1-4.
53. Nelkin, D. & Andrews, L. (1999) DNA identification and surveillance creep. Conrad, P. & Gabe, J. (eds) Sociological Perspectives on the New Genetics (Oxford, Blackwell), pp. 190-208.
54. Nelkin, D. & Lindee, S. (1995) The DNA Mystique: The Gene as a Cultural Icon (New York, W.H. Freeman).
55. Newman, S.A. (1988a) Does human genetic engineering have a scientific basis? Report from the Center for Philosophy and Public Policy, 8, pp. 6-9.
56. Newman, S.A. (1988b) Idealist biology. Perspectives in Biological Medicine, 31, pp. 353-368.
57. Newman, S.A. & Muller, G.B. (2000) Epigenetic mechanisms of character origination. Journal of Experimental Zoology, 288(4), pp. 304-317.
58. Newman, S. (2001) Embryo stem cells and biobusiness at 20. Gene Watch, 14, pp. 5-6 http://www.gene-watch.org/magazine/voll 4/14-6biobusiness.html.
59. Newman, S. & Raffensperger, C. (2000) Genetic Manipulation and the Precautionary Principle. In: Norton, P.A. and Steel, L.F. (eds) Genetransfer Methods: Introducing DNA into Living Cells and Organisms (Natick, MA, BioTechniques Books).
60. NIEHS (1999) National Institute of Environmental Health Sciences Environmental Genome Project. http://www.niehs.nih.gov.envgenom/concept.htm.
61. Novas, C. & Rose, N. (2000) Genetic risk and the birth of the somatic individual. Economy and Society, 29, pp. 485-513.
62. Olynyk, J.K., Cullen, D.J., Aquilia, S., Rossi, E., Summerville, L. & Powell, L.W. (1999) A population-based study of the clinical expression of the hemochromatosis gene. New England Journal of Medicine, 341, pp. 718-724.
63. Parke, D.V. (1991) Nutritional requirements for detoxification of environmental chemicals. Food Additives and Contaminants, 8, pp. 381-396.
64. Paterson, S.J., Brown, J.H., Gsodl, M.K., Johnson, M.H. & Karmiloff-Smith, A. (1999) Cognitive modularity and genetic disorders. Science, 286(5448), pp. 2355-2358.
65. Petersen, A. (2001) Biofantasies: genetics and medicine in the print news media. Social Science & Medicine 52, pp. 1255-1268.
66. Pietrangelo, A., Montosi, G., Totaro, A., Garuti, C., Conte, D., Cassanelli, S., Fraquelli, M., Sardini, C., Vasta, F. & Gasparini, P. (1999) Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. New England Journal of Medicine, 341, pp. 725-732.
67. Preston, R. (2000) The genome warrior. The New Yorker, 76, pp. 66-83.
68. Riddihough, G. & Pennisi, E. (2001) The evolution of epigenetics. Science, 293, p. 1063.
69. Rosenberg, L.E. & Schechter, A.N. (2000) Editorial: Gene therapist, heal thyself. Science, 287(5459), p. 1751.
70. Saltus, R. (2000) After bad gene found, no quick leap to a cure. Boston Globe, A01.
71. Scriver, C.R. & Waters, P.J. (1999) Monogenic traits are not simple: lessons from phenylketonuria. Trends in Genetics, 15(7), pp. 267-272.
72. Sigmund, C.D. (2000) Viewpoint: are studies in genetically altered mice out of control? Arteriosclerosis, Thrombosis and Vascular Biology, 20, pp. 1425-1429.
73. Smith, A.G. (2001a) Embryo-derived stem cells: of mice and men. Annual Review of Cell Development Biology, 17, pp. 435-462.
74. Smith, L.L. (2001b) Key challenges for toxicologists in the 21st century. Trends in Pharmacological Sciences, 22, pp. 281-285.
75. Specter, M. (2000) The pharmageddon riddle. The New Yorker, 76, pp. 58-71.
76. Stein, J., Schettler, T., Wallinga, D. & Valenti, M. (2002) In harm's way: toxic threats to child development. Journal of Developmental and Behavioral Pediatrics, 23, pp. S13-22.
77. Stephens, J., Flaherty, M.P., Nelson, D., LaFlaniere, S., Pomfret, J., DeYoung, K. & Struck, D. (2000) The body hunters: international clinical drug testing. Washington Post. December 17-21, p. A01. http://www.washingtonpost.com/wp-dyn/world/issues/bodyhunters/ Website includes entire series and is a preferable reference.
78. Stock, G. & Campbell, J. (2000) Engineering the Human Germline: An Exploration of the Science and Ethics of Altering the Genes We Pass to Our Children (Oxford, Oxford University Press).
79. Strohman, R.C. (1993) Ancient genomes, wise bodies, unhealthy people: limits of a genetic paradigm in biology and medicine. Perspectives in Biological Medicine, 37, pp. 112-145.
80. Strohman, R.C. (2000) Organization becomes cause in the matter. Nature Biotechnology, 18, pp. 575-576.
81. Taylor, P. & Haila, Y. (2001) Situatedness and problematic boundaries: conceptualizing life's complex ecological context. Biology & Philosophy, 16, pp. 521-532.
82. Van Den Belt, H. & Gremmen, B. (2002) Between precautionary principle and 'sound science': distributing the burdens of proof. Journal of Agricultural & Environmental Ethics, 15, pp. 103-122.
83. Wahlsten, D. (1999) Single-gene influences on brain and behavior. Annual Review of Psychology, 50, pp. 599-624.
84. Warhurst, M. (2000) Crisis in chemicals: the threat posed by the biomedical revolution to the profits, liabilities and regulation of industries making and using chemicals. http://www.foe.co.uk/pubsinfo/infoteam/presstel/2000/2000605085125.htm.
85. Weatherall, D. (1999) From genotype to phenotype: genetics and medical practice in the new millenium. Philosophical Transactions of the Royal Society of London B, 354, pp. 1995-2010.
86. Wunder, M. (1999) Biomedicine and Bioethics-The Human Being as Optimisation Project. http://www.bidok.uibk.ac.at/texte/wunder-bio-englisch.htm.
87. Wunder, M. (2000) Medicine and conscience: the debate on medical ethics and research in Germany 50 years after Nuremberg. Perspectives in Biology and Medicine, 43, pp. 373-381.